SBIR-STTR Award

MultiDimensional Expert System for Flow Cytometry
Award last edited on: 5/24/04

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$96,750
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Michael R Loken

Company Information

Hematologics Inc

113 First Avenue North
Seattle, WA 98109
   (206) 223-2700
   clientservices@hematologics.com
   www.hematologics.com
Location: Single
Congr. District: 07
County: King

Phase I

Contract Number: 1R43CA107747-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2004
Phase I Amount
$96,750
Multidimensional flow cytometry allows the discrimination of neoplastic cells from their normal counterparts. Using technology for the simultaneous measurement of 6 parameters, the abnormal expression of normal antigens can be used to identify leukemic populations. Distinction between normal and abnormal cells can be made by a highly trained scientist using a computer program which permits visualization of multidimensional data. This proposal will demonstrate the utility of a software program to reproduce the identification made by a trained scientist. We will focus on antigen expression on B lymphoid cells in bone marrow specimens that exhibit normal phenotypes. The software will follow the biological rules established by the trained scientist to identify the locations of normal cells in multidimensional space. Using this technology we will characterize acute lymphoblastic leukemias and report their relative positions in a multidimensional data space. We will mimic residual disease detection by combining normal and abnormal data to assess the value of the software technology in facilitating the identification of low levels of tumor cells in a background of normal cells.

Thesaurus Terms:
acute lymphocytic leukemia, computer assisted diagnosis, computer program /software, computer system design /evaluation, flow cytometry, neoplasm /cancer diagnosis B lymphocyte, antigen, bone marrow, cell population study, diagnosis design /evaluation, diagnostic test, gene expression, lymphoblast, neoplastic cell bioengineering /biomedical engineering, clinical research, human tissue, patient oriented research

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----